Patient-derived bladder cancer organoid model to predict sensitivity and feasibility of tailored precision therapy
{{output}}
Background: Bladder cancer is a common and highly heterogeneous malignant tumor with a relatively poor prognosis. Thus, personalized treatment strategies for bladder cancer are essential for improving patient outcomes. ... ...
